Non-invasive determination of conditions in the circulatory system of a subject

• US 7,070,569 B2
• Filed: 03/04/2002
• Issued: 07/04/2006
• Est. Priority Date: 03/05/2001
• Status: Expired due to Term

• Current Assignee: Instrumentarium Dental Incorporated (Envista Holdings Corporation)
• Original Assignee: Instrumentarium Dental Incorporated (Envista Holdings Corporation)
• Inventors: Ekstrom, Jan, Heinonen, Erkki
• Primary Examiner(s): Nasser, Robert L.
• Assistant Examiner(s): Natnithithadha, Navin
• Application Number:
  US10/091,169
• Publication Number:
  US 20020169385A1
• Time in Patent Office: 1,583 Days
• Field of Search: 600531-533, 600/538, 600/529, 600/481, 600483-486, 600490-503
• US Class Current: 600/532
• CPC Class Codes: A61B 5/029 Measuring or recording blood output from the heart, e.g. minute volume A61B8/065 takes precedence
• CPC Class Codes: A61B 5/0836 Measuring rate of CO2 production

Abstract

A method for non-invasively determining functional cardiac output (FCO) and/or venous blood CO₂ partial pressure (PvCO₂). The amount of CO₂ (VCO₂^N) released from the blood and end capillary blood CO₂ content (CcCO₂^N) are determined from measurements from exhaled breathing gases. The CO₂ content of the breathing gases inhaled by the subject is increased and values for VCO₂^R and CcCO₂^R are obtained. A regression analysis is performed using the obtained VCO₂^N, VO₂^R, CcCO₂^N, and CcCO₂^R values. The regression line is extrapolated to obtain a value for CcCO₂ when (VCO₂) is zero so that CvCO₂ becomes known. The CvCO₂ thus determined can be inserted in a non-differential form in the Fick equation, along with VCO₂ and CcCO₂ values from normal breathing, to determine FCO. To determine PvCO₂, CvCO₂ is altered in accordance with the amount of oxygen in the venous blood, to correctly indicate PvCO₂. The continuing validity of the FCO measurement can be examined on a breath-by-breath basis by noting changes in an indicator variable, such as VCO₂ or end tidal CO₂ amounts.

Claims

1. A method for non-invasively determining a condition of the circulatory system of a subject, the subject inhaling and exhaling breathing gases during breathing, said method comprising the steps of:

(a) measuring the amount of CO₂ in the breathing gases exhaled by the subject and the CO₂ concentration of the breathing gases exhaled by the subject for a first (1) breathing condition of the subject;

(b) determining at least one value of the amount of CO₂ released from the circulatory system of the subject (VCO₂¹) using the amount of CO₂ in the breathing gases exhaled when the subject is in the first condition;

(c) determining at least one value for a quantity indicative of the end capillary blood CO₂ content of the subject using the CO₂ concentration of the breathing gases exhaled when the subject in the first condition;

(d) altering the CO₂ concentration in the lungs of the subject;

(e) measuring the amount of CO₂ in the breathing gases exhaled by the subject and the CO₂ concentration of the breathing gases exhaled by the subject for at least one breath of the subject under a second (2) breathing condition of altered CO₂ in the lungs of the subject;

(f) determining at least one value for the amount of CO₂ released from the circulatory system of the subject (VCO₂²), the determination of the value being carried out in a time period less than that required for blood leaving the lungs of the subject to pass through the circulatory system of the subject and return to the lungs, the determination of the value using the amount of CO₂ in the exhaled breathing gases for the second breathing condition;

(g) determining at least one value for a quantity indicative of the end capillary blood CO₂ content of the subject, the determination of the value being carried out in a time period less than that required for blood leaving the lungs of the subject to pass through the circulatory system of the subject and return to the lungs, the determination of the value using the CO₂ concentration of the breathing gases exhaled for the second breathing condition;

(h) performing a regression analysis using the determined VCO₂¹, VCO₂², and end capillary blood CO₂ quantity values to establish a regression line;

(i) extrapolating the regression line to obtain a value for the end capillary blood CO₂ quantity when the amount of CO₂ released from the circulatory system of the subject (VCO₂) is zero;

determining a further value for the quantity indicative of the end capillary blood CO₂ content for breathing of the subject in the first breathing condition;

forming a relationship between the value for the quantity indicative of the end capillary blood CO₂ content for breathing in the first breathing condition used in the regression analysis and the value obtained by extrapolating the regression line in step (i); and

applying the relationship to the further determined value for a quantity indicative of the end capillary blood CO₂ content to provide a new value for the value which was obtained by the extrapolation of the regression line in step (i).

2. The method according to claim 1 wherein steps (a) and (e) are further defined as measuring end tidal CO₂ concentrations of the breathing gases exhaled by the subject.

3. The method according to claim 2 further defined in that the quantity, for which values are determined in steps (c) and (g), comprises the end tidal CO₂ concentration of the exhaled breathing gases and that the value obtained in step (i) is the end tidal CO₂ concentration when the amount of CO₂ released from the circulatory system of the subject (VCO₂) is zero.

4. The method according to claim 3 further including the step of using the value obtained in step (i) to determine the functional cardiac output (FCO) of the subject using a non-differential form of the Fick equation.

5. The method according to claim 1 further defined in that the quantity, for which the values are determined in steps (c) and (g), comprises the CO₂ partial pressure in the blood of the subject and that the value obtained in step (i) is the CO₂ partial pressure of the end capillary blood of the subject when the amount of CO₂ released from the circulatory system of the subject (VCO₂) is zero.

6. The method according to claim 5 further including the step of using the value obtained in step (i) to determine the functional cardiac output (FCO) of the subject using a non-differential form of the Fick equation.

7. The method according to claim 1 or 2 further defined in that the quantity, for which the values are determined in steps (c) and (g), comprises the CO₂ content of the end capillary blood (CcCO₂) of the subject and that the value obtained in step (i) is the CO₂ content of the end capillary blood of the subject when the amount of CO₂ released from the circulatory system of the subject (VCO₂) is zero, which value comprises the CO₂ content of venous blood (CvCO₂).

8. The method according to claim 7 further defined as including the steps of:

determining the amount of oxygen in the venous blood of the subject; and

altering the obtained value for the venous blood CO₂ content (CvCO₂) in accordance with the amount of oxygen in the blood to provide a CO₂ partial pressure value (PvCO₂) for venous blood.

9. The method according to claim 8 wherein the step of the determining the amount of oxygen in the venous blood is further defined as determining the degree of oxygen saturation of the venous blood.

10. The method according to claim 8 further defined as including the steps of:

determining a further value for the quantity indicative of the end capillary blood CO₂ content for breathing of the subject in the first breathing condition;

forming a relationship between the value for the quantity indicative of the end capillary blood CO₂ content for breathing in the first breathing condition used in the regression analysis and the CvCO₂ value obtained by extrapolating the regression line in step (i);

applying the relationship to the further determined value for a quantity indicative of the end capillary blood CO₂ content to provide a new CvCO₂ value; and

altering the new CvCO₂ value in accordance with the amount of oxygen in the blood to provide a new CO₂ partial pressure value (PvCO₂) for venous blood.

11. The method according to claim 10 further defined as forming a relationship comprising a ratio.

12. The method according to claim 10 further defined as forming a relationship comprising a difference.

13. The method according to claim 8 further defined as carrying out the method on a breath-by-breath basis.

14. The method according to claim 7 further including the step of using the value obtained in step (i) to determine the functional cardiac output (FCO) of the subject using a non-differential form of the Fick equation.

15. The method according to claim 1 further including the step of using the value obtained in step (i) to determine the functional cardiac output (FCO) of the subject using a non-differential form of the Fick equation.

16. The method according to claim 1 further defined as including the steps of:

determining further values for the amount of CO₂ released from the circulatory system of the subject (VCO₂) and for the quantity indicative of the end capillary blood CO₂ content for breathing of the subject in the first breathing condition; and

using the value provided by the extrapolation of the regression line in step (i) and a further determined released CO₂ amount (VCO₂) and value for the quantity indicative of end capillary blood CO₂ content to determine the functional cardiac output of the subject using a non-differential form of the Fick equation.

17. The method according to claim 16 further defined as being carried out on a breath-by-breath basis.

18. The method according to claim 1 further defined as forming a relationship comprising as a ratio.

19. The method according to claim 1 further defined as forming a relationship comprising a difference.

20. The method according to claim 1 further including the steps of:

determining further values for the amount of CO₂ released from the circulatory system of the subject (VCO₂^N) for breathing of the subject in the first breathing condition; and

using the further determined released CO₂ amount (VCO₂¹), the further determined value for a quantity indicative of the end capillary blood CO₂ content, and the new value for the value which was obtained by extrapolation of the regression line in a non-differential form of the Fick equation to determine the functional cardiac output (FCO) of the subject.

21. The method according to claim 1 further defined as being carried out on a breath-by-breath basis.

22. The method according to claim 1 wherein the step of altering the CO₂ concentration in the lungs of the subject is further defined as increasing the CO₂ concentration in the lungs of the subject to reduce CO₂ gas exchange in the lungs of the subject.

23. The method according to claim 22 wherein the step of increasing the CO₂ concentration in the lungs of the subject is further defined as increasing the CO₂ content of the breathing gases inhaled by the subject.

24. The method according to claim 23 further defined as administering a bolus of CO₂ into the breathing gas inhaled by the subject.

25. The method according to claim 23 further defined as causing the subject to inhale breathing gas previously exhaled by the subject.

26. The method according to claim 23 wherein step (d) is further defined as increasing the CO₂ by an amount which improves the accuracy of the determination while avoiding undue build up of CO₂ in the blood of the subject.

27. The method according to claim 1 wherein the step of altering the CO₂ concentration in the lungs of the subject is further defined as decreasing the CO₂ concentration in the lungs of the subject to increase CO₂ gas exchange in the lungs of the subject.

28. The method according to claim 27 wherein the step of decreasing the CO₂ concentration in the lungs of the subject is further defined as increasing the ventilation of the subject.

29. The method according to claim 1 further defined as performing linear regression analysis using the VCO₂¹, VCO₂², and values for the quantity indicative of the end capillary blood CO₂ content of the subject determined using the exhaled breathing gas CO₂ concentrations for the first and second conditions.

30. The method according to claim 1 where the breathing gases supplied to the subject comprise air.

31. The method according to claim 1 further including the step of allowing the subject to take a sufficient number of breaths to stabilize the CO₂ content and CO₂ concentration of the exhaled breathing gases before taking the breathing measurements for the first breathing condition of the subject.

32. The method according to claim 1 further defined as determining a plurality of values for at least one of the amount of CO₂ released from the circulatory system of the subject (VCO₂) and the quantity indicative of the end capillary blood CO₂ content for use in performing the regression analysis.

33. The method according to claim 1 wherein steps (b) and (f) are further defined as determining at least one value of the amount of CO₂ released from the circulatory system of the subject (VCO₂) using the CO₂ content of the inhaled and exhaled breathing gases.

34. A method for determining a change in a measured condition of the circulatory system of a subject, said method comprising the steps of:

(a) non-invasively obtaining, from the subject, an initial value for at least one selected variable comprising at least one of exhaled CO₂ amount, end tidal CO₂ amount, heart rate, and the amount of CO₂ released from the circulatory system of the subject (VCO₂);

(b) carrying out a discrete measurement of a circulatory system condition of a subject;

(c) obtaining a further value for the at least one selected variable subsequent to carrying out the discrete measurement;

(d) comparing the further value of the variable with the initial value of said variable to determine whether the obtained variable has changed in value; and

(e) initiating a carrying out of a further discrete measurement of a circulatory system condition of the subject responsive to a change in the value of the variable.

35. The method according to claim 34 further defined compensating the values of the selected variable for changes in the condition of the subject not arising from circulatory system conditions.

36. The method according to claim 35 further defined as compensating a selected variable for changes in ventilation of the subject.

37. The method according to claim 34 wherein the discrete measurement of circulatory system condition in steps (b) and (e) is carried out using a non-differential form of the Fick Equation and the quantities expressed therein and the circulatory system condition is the functional cardiac output (FCO).

38. The method according to claim 34 wherein the discrete measurement of circulatory system condition in steps (b) and (e) is carried out using a differential form of the Fick Equation and the quantities expressed therein.

39. The method according to claim 38 wherein the at least one selected variable further comprises at least one of the amount of CO₂ released from the circulatory system of the subject (VCO₂) and the end tidal CO₂ amount for normal conditions of the subject.

40. The method according to claim 38 wherein the measured circulatory system condition is functional cardiac output (FCO).

41. The method according to claim 34 wherein the discrete measurements of circulatory system condition are carried out using the quantifies expressed in a differential form of the Fick Equation and the circulatory system condition is venous blood partial CO₂ pressure (PvCO₂).

42. The method according to claim 40 wherein the at least one selected variable further comprises at least one of the amount of CO2 released from the circulatory system of the subject (VCO2) and end tidal CO2 for normal conditions of the subject.

43. The method according to claim 34 wherein the discrete measurement of the circulatory system condition in step (b) is carried out using a blood dilution technique.

44. The method according to claim 43 wherein the blood dilution technique uses a marker dye.

45. The method according to claim 43 wherein the blood dilution technique uses thermodilution.

46. The method according to claim 43 wherein the circulatory system condition measured is cardiac output (CO).

47. The method according to claim 34 wherein step (c) is further defined as sequentially obtaining further values of the at least one variable for comparison with the initial value.

48. The method according to claim 47 further defined as obtaining further values on a breath-by-breath basis.

49. The method according to claim 47 further defined as obtaining further values on a heart beat by heart beat basis.

50. The method according to claim 34 further defined as allowing disturbances caused by the carrying out of the discrete measurement to subside before obtaining a further value for said at least one selected variable.

51. The method according to claim 38 further defined as allowing disturbances caused by the carrying out of the discrete measurement to subside before obtaining a further value for said at least one variable.

52. The method according to claim 34 wherein step (d) is further defined as determining whether the variable has changed by a predetermined amount.

53. The method according to claim 34 further defined as providing an indication that a change in the value of the variable has occurred.

54. The method according to claim 34 further defined as providing an indication of the amount by which the value of the variable has changed.

55. The method according to claim 34 further defined as providing an indication of the direction in which a change in the value of the variable has occurred.

56. The method according to claim 34 further defined as providing an alarm.

57. Apparatus for determining a change in a measured condition of the circulatory system of a subject, said apparatus comprising:

(a) means for non-invasively obtaining, from the subject, an initial value and subsequent value for at least one selected selected variable comprising at least one of exhaled CO₂ amount, end tidal CO₂ amount, heart rate, and the amount of CO₂ released from the circulatory system of the subject (VCO₂);

(b) means for carrying out a discrete measurement of a circulatory system condition of a subject;

(c) means for comparing the subsequent value of the variable with the initial value of said variable to determine whether the obtained variable has changed in value and for causing said means for carrying out a discrete measurement to carry out a further discrete measurement of a circulatory system condition of the subject responsive to a change in the value of the variable.

58. The apparatus according to claim 57 further defined as including means for compensating the values of the selected variable for changes in the condition of the subject not arising from circulatory system conditions.

59. The apparatus according to claim 57 wherein the measured circulatory system condition is functional cardiac output (FCO).

60. The apparatus according to claim 57 wherein the measured circulatory system condition is venous blood partial CO₂ pressure (PvCO₂).

61. The apparatus according to claim 57 wherein the measured circulatory system condition is cardiac output.

62. The apparatus according to claim 57 wherein the circulatory system condition is measured non-invasively.

63. The apparatus according to claim 57 wherein the circulatory system condition is measured invasively.